Biofarm Statistics
Total Valuation
Biofarm has a market cap or net worth of RON 760.70 million. The enterprise value is 628.63 million.
Market Cap | 760.70M |
Enterprise Value | 628.63M |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | Aug 20, 2024 |
Share Statistics
Biofarm has 985.37 million shares outstanding. The number of shares has increased by 9.62% in one year.
Shares Outstanding | 985.37M |
Shares Change (YoY) | +9.62% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 88.46% |
Float | 477.14M |
Valuation Ratios
The trailing PE ratio is 12.10.
PE Ratio | 12.10 |
Forward PE | n/a |
PS Ratio | 2.93 |
PB Ratio | 1.71 |
P/FCF Ratio | 21.49 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.40, with an EV/FCF ratio of 17.76.
EV / Earnings | 9.13 |
EV / Sales | 2.42 |
EV / EBITDA | 7.40 |
EV / EBIT | 9.27 |
EV / FCF | 17.76 |
Financial Position
The company has a current ratio of 3.82
Current Ratio | 3.82 |
Quick Ratio | 3.08 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 33,894,522.00 |
Financial Efficiency
Return on equity (ROE) is 16.28% and return on invested capital (ROIC) is 10.01%.
Return on Equity (ROE) | 16.28% |
Return on Assets (ROA) | 8.29% |
Return on Capital (ROIC) | 10.01% |
Revenue Per Employee | 685,929 |
Profits Per Employee | 182,250 |
Employee Count | 399 |
Asset Turnover | 0.51 |
Inventory Turnover | 0.79 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.26% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +0.26% |
50-Day Moving Average | 0.79 |
200-Day Moving Average | 0.81 |
Relative Strength Index (RSI) | 41.95 |
Average Volume (20 Days) | 18,430 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biofarm had revenue of RON 259.28 million and earned 68.89 million in profits. Earnings per share was 0.06.
Revenue | 259.28M |
Gross Profit | 215.62M |
Operating Income | 67.79M |
Pretax Income | 76.76M |
Net Income | 68.89M |
EBITDA | 84.89M |
EBIT | 67.79M |
Earnings Per Share (EPS) | 0.06 |
Balance Sheet
Cash & Cash Equivalents | 132.08M |
Total Debt | n/a |
Net Cash | 132.08M |
Net Cash Per Share | 0.13 |
Equity (Book Value) | 445.86M |
Book Value Per Share | 0.45 |
Working Capital | 224.11M |
Cash Flow
In the last 12 months, operating cash flow was 72.95 million and capital expenditures -37.55 million, giving a free cash flow of 35.40 million.
Operating Cash Flow | 72.95M |
Capital Expenditures | -37.55M |
Free Cash Flow | 35.40M |
FCF Per Share | 0.04 |
Margins
Gross margin is 83.16%, with operating and profit margins of 26.14% and 26.57%.
Gross Margin | 83.16% |
Operating Margin | 26.14% |
Pretax Margin | 29.61% |
Profit Margin | 26.57% |
EBITDA Margin | 32.74% |
EBIT Margin | 26.14% |
FCF Margin | 13.65% |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 3.98%.
Dividend Per Share | 0.03 |
Dividend Yield | 3.98% |
Dividend Growth (YoY) | 3.33% |
Years of Dividend Growth | 2 |
Payout Ratio | 40.97% |
Buyback Yield | -9.62% |
Shareholder Yield | -5.63% |
Earnings Yield | 8.26% |
FCF Yield | 4.65% |
Stock Splits
The last stock split was on April 30, 2008. It was a forward split with a ratio of 1.12001.
Last Split Date | Apr 30, 2008 |
Split Type | Forward |
Split Ratio | 1.12001 |
Scores
Biofarm has an Altman Z-Score of 8.14.
Altman Z-Score | 8.14 |
Piotroski F-Score | n/a |